Digital breast tomosynthesis (DBT) represent a new breast imaging technology recently approved by the FDA with the potential to increase cancer detection while significantly reducing the need for call back and follow up examinations. The Breast Imaging Division at the Hospital of the University of Pennsylvania will transition its screening practice that to DBT. Project 1 will take advantage of the transition DBT to measure screening related outcomes, xray dose and costs associated with routine DBT based screening and compare it to a cohort screened with planar digital mammography (DM). During the transition, patients will either undergo DBT or DM screening on a first come first serve basis. The comparison cohort will be the population screened at HUP with DM. Screening outcomes measured include call backs, follow ups, Ultrasound exams, biopsies and cancer. Mean gladular xray dose will be calculated for every projection of DM and DBT exams. Costs associated with the screening exam, and downstream costs associated with the diagnostic work up will be measured in both cohorts. Patients will be surveyed to determine the effect of DBT on satisfaction with the screening process and breast cancer worry. Given the lack of data related to the impact of DBT on breast cancer screening outcomes, project 1 will generate critical data to inform the more widespread implementation of this new technology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA163313-04
Application #
8715726
Study Section
Special Emphasis Panel (ZCA1-SRLB-R)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
4
Fiscal Year
2014
Total Cost
$220,958
Indirect Cost
$98,723
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Onega, Tracy; Beaber, Elisabeth F; Sprague, Brian L et al. (2014) Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level. Cancer 120:2955-64
Keller, Brad M; Chen, Jinbo; Conant, Emily F et al. (2014) Breast density and parenchymal texture measures as potential risk factors for Estrogen-Receptor positive breast cancer. Proc SPIE Int Soc Opt Eng 9035:90351D
McCarthy, Anne Marie; Kontos, Despina; Synnestvedt, Marie et al. (2014) Screening outcomes following implementation of digital breast tomosynthesis in a general-population screening program. J Natl Cancer Inst 106:
McCarthy, Anne Marie; Armstrong, Katrina (2014) The role of testing for BRCA1 and BRCA2 mutations in cancer prevention. JAMA Intern Med 174:1023-4
Conant, Emily F (2014) Clinical implementation of digital breast tomosynthesis. Radiol Clin North Am 52:499-518
Keller, Brad M; Nathan, Diane L; Gavenonis, Sara C et al. (2013) Reader variability in breast density estimation from full-field digital mammograms: the effect of image postprocessing on relative and absolute measures. Acad Radiol 20:560-8
Daye, Dania; Keller, Brad; Conant, Emily F et al. (2013) Mammographic parenchymal patterns as an imaging marker of endogenous hormonal exposure: a preliminary study in a high-risk population. Acad Radiol 20:635-46